The downregulation of SIRT1/2 can induce protective autophagy in lung cancer by increasing the acetylation of HSPA5, which in turn elevates ATF4 and DDIT4 levels, suppressing mTOR and promoting pro-survival autophagy (Mu et al., 2019). Here, SIRT1 is linked to lung carcinoma.